Insider: Hamilton James C Chief Medical Officer - ARROWHEAD PHARMACEUTICALS, INC.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 232,122 | 0 | 232,122 |
| Value | $7,416,297.90 | $0.00 | $7,416,297.90 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 09/12/2025 | DDS | 15,000 | Direct | COM | $30.00 | $450,000.00 | 232,122 |
| 09/02/2025 | DDS | 15,000 | Direct | COM | $25.00 | $375,000.00 | 247,122 |
| 08/15/2025 | DDS | 9,389 | Direct | COM | $20.00 | $187,780.00 | 262,122 |
| 08/13/2025 | DDS | 611 | Direct | COM | $20.00 | $12,220.00 | 271,511 |
| 04/01/2024 | DDS | 6,000 | Direct | COM | $28.03 | $168,180.00 | 204,851 |
| 01/12/2024 | DDS | 4,238 | Direct | COM | $36.47 | $154,559.86 | 214,553 |
| 01/12/2024 | DDS | 3,702 | Direct | COM | $37.37 | $138,343.74 | 210,851 |
| 06/30/2023 | DDS | 3,000 | Direct | COM | $35.53 | $106,590.00 | 188,484 |
| 01/05/2023 | DDS | 7,230 | Direct | COM | $37.40 | $270,402.00 | 198,057 |
| 01/05/2023 | DDS | 6,573 | Direct | COM | $37.40 | $245,830.20 | 191,484 |
| 01/03/2023 | DDS | 2,837 | Direct | COM | $38.53 | $109,309.61 | 151,594 |
| 01/03/2023 | DDS | 1,194 | Direct | COM | $37.46 | $44,727.24 | 154,431 |
| 01/03/2023 | DDS | 300 | Direct | COM | $39.74 | $11,922.00 | 151,294 |
| 01/03/2023 | DDS | 136 | Direct | COM | $40.54 | $5,513.44 | 151,158 |
| 01/03/2023 | DDS | 247 | Direct | COM | $40.52 | $10,008.44 | 145,287 |
| 01/03/2023 | DDS | 300 | Direct | COM | $39.56 | $11,868.00 | 145,534 |
| 01/03/2023 | DDS | 3,682 | Direct | COM | $38.52 | $141,830.64 | 145,834 |
| 01/03/2023 | DDS | 1,642 | Direct | COM | $37.49 | $61,558.58 | 149,516 |
| 01/05/2022 | DDS | 2,290 | Direct | COM | $60.51 | $138,567.90 | 159,585 |
| 01/05/2022 | DDS | 2,100 | Direct | COM | $61.84 | $129,864.00 | 157,485 |
| 01/05/2022 | DDS | 60 | Direct | COM | $64.35 | $3,861.00 | 155,625 |
| 01/05/2022 | DDS | 1,100 | Direct | COM | $62.64 | $68,904.00 | 156,385 |
| 01/05/2022 | DDS | 700 | Direct | COM | $63.68 | $44,576.00 | 155,685 |
| 01/04/2022 | DDS | 9,955 | Direct | COM | $64.89 | $645,979.95 | 171,295 |
| 01/04/2022 | DDS | 7,469 | Direct | COM | $65.59 | $489,891.71 | 163,826 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research